
View larger version (40K):
[in a new window]
|
Fig. 1. Generation of Tbx20 null mice. (A) Schematic representation of the
wild-type Tbx20 locus (exons I-IV indicted as black boxes) above the
Tbx20 targeting construct and targeted Tbx20Flox
and Tbx20lacZ alleles. Arrows represent the direction of
transcription of neomycin (neo) and lacZ genes. Neo is driven by the
phosphoglycerokinase promoter. Arrowheads represent loxP sites. P1 and P2
indicate 5' and 3' Southern screening probes. (B,C) Validation of
the primary targeting event in embryonic stem cells using Southern analysis of
ScaI- and NcoI-digested DNA and probes P1 and P2. (D) PCR
genotyping assay detecting wild-type (174 bp), Floxed (220 bp) and/or
Cre-deleted (302 bp) Tbx20 alleles in mice or embryos of indicated
genotypes. (E) RT-PCR analysis of RNA extracted from wild-type or
Tbx20lacZ/lacZ embryonic hearts demonstrating deletion of
exons I-III and preservation of exons IV-VI (read-through from lacZ
cassette) in the mutant. (F-I) Expression of lacZ in
Tbx20lacZ/+ embryos at E7.5-10.5. am, amniotic mesoderm;
cp, cardiac progenitors; da, dorsal aorta; e, eye primordium; ecc, endocardial
cushion; en, endothelium; h, heart; hb, hindbrain; ias, inter-atrial septum;
la, left atrium; N, NcoI; neo, neomycin; nt, neural tube; pe,
pharyngeal endoderm; ra, right atrium; S, ScaI; v, ventricle; wt,
wild type; ysm, yolk sac mesoderm.
|